World Journal of Gastroenterology · 2005 · 19 citations · 28 references
MedicineGeneticsOncologyCancer GeneticsMedical GeneticsMolecular OncologyColorectal CancerGermline Cancer PredispositionGermline Cancer SusceptibilityGermline Variant AnalysisHereditary Cancer SyndromesMutation AnalysisDisease-causing VariantsGermline MutationsHereditary Cancer PedigreesImmunohistochemical DetectionImmunohistochemical StainingMissense MutationsMutationMutational Spectra
AIM: To investigate the prevalence and penetrance of hMSH6 mutations in Spanish HNPCC families that was negative for mutation in hMLH1 or hMSH2. METHODS: We used PCR-based DGGE assay and direct sequencing to screen for hMSH6 gene in 91 HNPCC families. RESULTS: we have identified 10 families with germ-line mutations in the DNA sequence. These mutations included two intronic variation, three missense mutation, one nonsense mutation, and four silent mutations. Among the 10 germ-line mutations identified in the Spanish cohort, 8 were novel, perhaps, suggesting different mutational spectra in the Spanish population. Detailed pedigrees were constructed for the three families with a possible pathogenic hMSH6 mutation. The two silent mutations H388H and L758L, detected in a person affected of colorectal cancer at age 29, produce loss of the wild-type allele in the tumor sample. Immunohistochemical analysis showed that expression of MSH6 protein was lost only in the tumors from the carriers of V878A and Q263X mutations. CONCLUSION: Altogether, our results indicate that disease-causing germ-line mutations of hMSH6 are very less frequent in Spanish HNPCC families.
28
C. Richard Boland, Stephen N. Thibodeau, Stanley R. Hamilton et al. · PubMed · 1998 · 4.1K citations
Life Sciences, Genetics, Oncology +17
Hans F. A. Vasen, Peter H. Watson, Jukka‐Pekka Mecklin et al. · Gastroenterology · 1999 · 2.5K citations · Full text
Life Sciences, Genetics, Oncology +17
Michelle Landon, Jennifer Saam, Krystal Brown et al. · Oncology · 2015 · 1.9K citations · Full text
Life Sciences, Genetics, Oncology +17